Australia markets closed

MEI Pharma, Inc. (MEIP)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.0500-0.0500 (-1.61%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 20.65M
Enterprise value -26.80M
Trailing P/E 1.04
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.28
Price/book (mrq)0.35
Enterprise value/revenue -0.37
Enterprise value/EBITDA -1.65

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3-39.10%
S&P500 52-week change 321.08%
52-week high 37.9700
52-week low 33.0341
50-day moving average 33.8574
200-day moving average 35.6838

Share statistics

Avg vol (3-month) 321.46k
Avg vol (10-day) 313.51k
Shares outstanding 56.66M
Implied shares outstanding 66.66M
Float 84.94M
% held by insiders 10.54%
% held by institutions 147.62%
Shares short (15 Apr 2024) 420.91k
Short ratio (15 Apr 2024) 41.03
Short % of float (15 Apr 2024) 40.38%
Short % of shares outstanding (15 Apr 2024) 40.31%
Shares short (prior month 15 Mar 2024) 49.1k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Dec 2023
Ex-dividend date 416 Nov 2023
Last split factor 21:20
Last split date 317 Apr 2023

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 27.31%
Operating margin (ttm)20.67%

Management effectiveness

Return on assets (ttm)8.30%
Return on equity (ttm)36.79%

Income statement

Revenue (ttm)72.65M
Revenue per share (ttm)10.90
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 15.38M
Net income avi to common (ttm)19.84M
Diluted EPS (ttm)2.9800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)59.48M
Total cash per share (mrq)8.93
Total debt (mrq)12.03M
Total debt/equity (mrq)20.22%
Current ratio (mrq)8.23
Book value per share (mrq)8.93

Cash flow statement

Operating cash flow (ttm)-52.98M
Levered free cash flow (ttm)433.62k